Healthcare Services

Tumor profiling market forecast with key trends

April 20, 2026April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Anticipated Rise In Market Value Of The Cancer Tumor Profiling Market During The Forecast Period?

The cancer tumor profiling market size has seen substantial expansion in recent years. It is projected to increase from $14.97 billion in 2025 to $17.1 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.3%. This historical growth can be attributed to several factors including the increasing utilization of tumor biopsy testing, the expansion of oncology research programs, the early clinical adoption of molecular stratification, the growth of hospital-based profiling services, and the rising availability of advanced laboratory infrastructure.

The cancer tumor profiling market size is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $28.27 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.4%. This anticipated growth during the forecast period stems from factors such as an escalating need for precision oncology decision-making, the widening scope of personalized cancer therapies, increasing capital directed towards translational research, the growing uptake of advanced sequencing technologies, and a heightened emphasis on predictive oncology diagnostics. Key developments expected during this period involve the rising application of multi-omics tumor profiling, the increasing acceptance of targeted sequencing panels, the expanding incorporation of AI-driven biomarker analysis, the broader development of personalized treatment planning, and an intensified focus on prognostic profiling.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report

What Key Drivers Are Fueling The Growth Of The Cancer Tumor Profiling Market?

The global increase in cancer cases is anticipated to drive forward the cancer and tumor profiling market. Cancer is a condition where certain body cells become excessively large and multiply without control, spreading to other parts of the body. As the number of individuals diagnosed with cancer rises, so does the demand for cancer tumor profiling, which enables medical professionals to ascertain the disease’s severity. For example, in 2024, the American Cancer Society, a US-based professional organization, reported that 2 million new cancer cases were diagnosed in the country, an increase from 1.9 million new cases in 2023. Consequently, the escalating worldwide incidences of cancer are fueling the growth of the cancer and tumor profiling market. The expanding occurrence of stomach cancer is expected to propel the growth of the cancer and tumor profiling market in the future. Stomach cancer refers to the unrestrained multiplication and growth of malignant cells within the stomach’s lining. While gastrointestinal stromal tumors (GISTs) can develop in the stomach, they are distinct from stomach cancer. When two separate tumors collide and merge into one, patients with GISTs have been observed to have an elevated risk of developing additional cancers, including small bowel adenocarcinoma. Cancer and tumor profiling offers insights into the development of cancer in the stomach, aiding in the provision of better treatment. For instance, according to Cancer Research UK, a UK-based independent cancer research organization, the incidence of stomach cancer in the UK is projected to fall by 12% between 2023-2025 and 2038-2040, reaching an average of 8 cases per 100,000 people each year. Therefore, the growing incidence of stomach cancer is driving the growth of the cancer and tumor profiling market.

What Are The Key Segment Divisions In The Cancer Tumor Profiling Market Segment Structure?

The cancer tumor profiling market covered in this report is segmented –

1) By Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Ovarian Cancer, Stomach Cancer, Pancreatic Cancer, Thyroid Cancer, Other Cancer Types

2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In Situ Hybridization (ISH), Microarray, Other Technologies

3) By Process Type: Genomics, Proteomics, Epigenetics, Other Types

4) By Application: Personalized Medicine, Diagnostics, Biomarker Discovery, Prognostics, Research Applications

Subsegments:

1) By Lung Cancer: Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC)

2) By Breast Cancer: Hormone Receptor-Positive, Triple-Negative Breast Cancer, HER2-Positive Breast Cancer

3) By Colorectal Cancer: Colon Cancer, Rectal Cancer

4) By Prostate Cancer: Localized Prostate Cancer, Advanced Prostate Cancer

5) By Melanoma: Cutaneous Melanoma, Non-Cutaneous Melanoma

6) By Ovarian Cancer: Epithelial Ovarian Cancer, Non-Epithelial Ovarian Cancer

7) By Stomach Cancer: Gastric Adenocarcinoma, Gastrointestinal Stromal Tumors (GISTs)

8) By Pancreatic Cancer: Exocrine Pancreatic Cancer, Neuroendocrine Tumors

9) By Thyroid Cancer: Papillary Thyroid Cancer, Follicular Thyroid Cancer, Medullary Thyroid Cancer

10) By Other Cancer Types: Kidney Cancer, Bladder Cancer, Liver Cancer, Esophageal Cancer

Which Organizations Are Engaged In The Cancer Tumor Profiling Market?

Major companies operating in the cancer tumor profiling market are F. Hoffmann-La Roche Ltd., Caris Life Sciences, Thermo Fisher Scientific Inc., Illumina Inc., Qiagen, HTG Molecular Diagnostics Inc., NanoString Technologies Inc., NeoGenomics Laboratories Inc., Lucence Health Inc., ACT Genomics Co. LTD, Strand Life Sciences, Exact Sciences Corporation, Guardant Health, Foundation Medicine Inc., Agilent Technologies Inc., Myriad Genetics Inc., Personal Genome Diagnostics Inc., Tempus Labs Inc., ArcherDX Inc., Natera Inc., Bio-Rad Laboratories Inc., Genetron Health, NantHealth Inc., Resolution Bioscience, OncoDNA, Strata Oncology Inc., RareCyte Inc., Inivata Limited, Cepheid

Get The Full Cancer Tumor Profiling Market Report:

https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report

Which Region Holds The Highest Market Share In The Cancer Tumor Profiling Market?

North America was the largest region in cancer and tumor profiling market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer tumor profiling market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Cancer Tumor Profiling Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report

Browse Through More Reports Similar to the Global Cancer Tumor Profiling Market 2026, By The Business Research Company

Cancer Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Cancer Profiling Market Report 2026

https://www.thebusinessresearchcompany.com/report/cancer-profiling-global-market-report

Cancer Biomarker Market Report 2026

https://www.thebusinessresearchcompany.com/report/cancer-biomarker-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795